Used primarily in pharmaceutical research as a key intermediate in the synthesis of proteasome inhibitors. It plays a role in the development of anticancer agents, particularly in targeting multiple myeloma and other hematologic malignancies. Its structure enables selective binding to proteasome subunits, enhancing the potency of therapeutic compounds. Also utilized in studies focusing on improving drug delivery and bioavailability of peptide-based drugs.